Innovation drug manufacturing site launched in Moscow

Print 17 November 2014
MARCHMONT Innovation News

A new production line has opened in Moscow’s Strogino Technopark to synthesize innovation drugs, the website of Moscow’s TVTs TV channel  reported. 

According to the website, the new Russian drugs are “superior in a range of parameters to German analogs” and are manufactured nowhere else in Russia. 

The drugs reportedly help improve cerebral blood circulation and prevent depressions. They are effective in preventing strokes, too, the source said. 

The new drugs are administered to the mucous membranes of a patient’s nasal cavity and are said to be able to quickly spread across organs and tissues, reaching a damaged area in the brain and preventing the death of cells. 

Starting with a capacity of 600,000 vials a year, the new site is expected to boost production sevenfold “very soon” to as many as four million.

Source

Return